Gene Symbol | RORA |
Entrez ID | 6095 |
Uniprot ID | P35398 |
Description | RAR-related orphan receptor A |
Chromosomal Location | chr15: 60,488,284-61,229,319 |
Ontology | GO ID | GO Term | Definition | Evidence |
---|---|---|---|---|
BP |
GO:0001525 |
angiogenesis |
Blood vessel formation when new vessels emerge from the proliferation of pre-existing blood vessels. |
IMP |
BP |
GO:0006355 |
regulation of transcription, DNA-templated |
Any process that modulates the frequency, rate or extent of cellular DNA-templated transcription. |
IDA |
BP |
GO:0006367 |
transcription initiation from RNA polymerase II promoter |
Any process involved in the assembly of the RNA polymerase II preinitiation complex (PIC) at an RNA polymerase II promoter region of a DNA template, resulting in the subsequent synthesis of RNA from that promoter. The initiation phase includes PIC assembly and the formation of the first few bonds in the RNA chain, including abortive initiation, which occurs when the first few nucleotides are repeatedly synthesized and then released. Promoter clearance, or release, is the transition between the initiation and elongation phases of transcription. |
TAS |
BP |
GO:0006805 |
xenobiotic metabolic process |
The chemical reactions and pathways involving a xenobiotic compound, a compound foreign to living organisms. Used of chemical compounds, e.g. a xenobiotic chemical, such as a pesticide. |
ISS |
BP |
GO:0006809 |
nitric oxide biosynthetic process |
The chemical reactions and pathways resulting in the formation of nitric oxide, nitrogen monoxide (NO), a colorless gas only slightly soluble in water. |
IEA |
BP |
GO:0008589 |
regulation of smoothened signaling pathway |
Any process that modulates the frequency, rate or extent of smoothened signaling. |
ISS |
BP |
GO:0010575 |
positive regulation of vascular endothelial growth factor production |
Any process that increases or activates the frequency, rate, or extent of production of vascular endothelial growth factor. |
IMP |
BP |
GO:0010906 |
regulation of glucose metabolic process |
Any process that modulates the rate, frequency or extent of glucose metabolism. Glucose metabolic processes are the chemical reactions and pathways involving glucose, the aldohexose gluco-hexose. |
ISS |
BP |
GO:0019218 |
regulation of steroid metabolic process |
Any process that modulates the frequency, rate or extent of the chemical reactions and pathways involving steroids. |
ISS |
BP |
GO:0021702 |
cerebellar Purkinje cell differentiation |
The process in which neuroblasts acquire specialized structural and/or functional features that characterize the mature cerebellar Purkinje cell. Differentiation includes the processes involved in commitment of a neuroblast to a Purkinje cell fate. A Purkinje cell is an inhibitory GABAergic neuron found in the cerebellar cortex that projects to the deep cerebellar nuclei and brain stem. |
IEA |
BP |
GO:0021930 |
cerebellar granule cell precursor proliferation |
The multiplication or reproduction of neuroblasts that will give rise to granule cells. A granule cell is a glutamatergic interneuron found in the cerebellar cortex. |
ISS |
BP |
GO:0030522 |
intracellular receptor signaling pathway |
Any series of molecular signals initiated by a ligand binding to an receptor located within a cell. |
IDA |
BP |
GO:0032922 |
circadian regulation of gene expression |
Any process that modulates the frequency, rate or extent of gene expression such that an expression pattern recurs with a regularity of approximately 24 hours. |
ISS |
BP |
GO:0036315 |
cellular response to sterol |
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a sterol stimulus. |
IDA|IMP |
BP |
GO:0042692 |
muscle cell differentiation |
The process in which a relatively unspecialized cell acquires specialized features of a muscle cell. |
IMP |
BP |
GO:0042753 |
positive regulation of circadian rhythm |
Any process that activates or increases the frequency, rate or extent of a circadian rhythm behavior. |
ISS |
BP |
GO:0043030 |
regulation of macrophage activation |
Any process that modulates the frequency or rate of macrophage activation. |
IEA |
BP |
GO:0043124 |
negative regulation of I-kappaB kinase/NF-kappaB signaling |
Any process that stops, prevents, or reduces the frequency, rate or extent of -kappaB kinase/NF-kappaB signaling. |
IMP |
BP |
GO:0043401 |
steroid hormone mediated signaling pathway |
A series of molecular signals mediated by a steroid hormone binding to a receptor. |
IEA |
BP |
GO:0045599 |
negative regulation of fat cell differentiation |
Any process that stops, prevents, or reduces the frequency, rate or extent of adipocyte differentiation. |
ISS |
BP |
GO:0045893 |
positive regulation of transcription, DNA-templated |
Any process that activates or increases the frequency, rate or extent of cellular DNA-templated transcription. |
IDA |
BP |
GO:0045944 |
positive regulation of transcription from RNA polymerase II promoter |
Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter. |
IDA |
BP |
GO:0046068 |
cGMP metabolic process |
The chemical reactions and pathways involving cyclic GMP, guanosine 3',5'-phosphate. |
IEA |
BP |
GO:0050728 |
negative regulation of inflammatory response |
Any process that stops, prevents, or reduces the frequency, rate or extent of the inflammatory response. |
IMP |
BP |
GO:0060850 |
regulation of transcription involved in cell fate commitment |
Any process that modulates the frequency, rate or extent of transcription from an RNA polymerase II promoter that contributes to the commitment of a cell to a specific fate. |
ISS |
BP |
GO:0070328 |
triglyceride homeostasis |
Any process involved in the maintenance of an internal steady state of triglyceride within an organism or cell. |
IMP |
BP |
GO:0071347 |
cellular response to interleukin-1 |
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an interleukin-1 stimulus. |
IEA |
BP |
GO:0071356 |
cellular response to tumor necrosis factor |
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a tumor necrosis factor stimulus. |
IEA |
BP |
GO:0071456 |
cellular response to hypoxia |
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating lowered oxygen tension. Hypoxia, defined as a decline in O2 levels below normoxic levels of 20.8 - 20.95%, results in metabolic adaptation at both the cellular and organismal level. |
IMP |
BP |
GO:0072539 |
T-helper 17 cell differentiation |
The process in which a relatively unspecialized T cell acquires the specialized features of a T-helper 17 (Th17) cell. A Th17 cell is a CD4-positive, alpha-beta T cell with the phenotype RORgamma-t-positive that produces IL-17. |
ISS |
BP |
GO:2000188 |
regulation of cholesterol homeostasis |
Any process that modulates the frequency, rate or extent of cholesterol homeostasis. |
ISS |
CC |
GO:0005634 |
nucleus |
A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent. |
IDA |
CC |
GO:0005654 |
nucleoplasm |
That part of the nuclear content other than the chromosomes or the nucleolus. |
TAS |
MF |
GO:0000977 |
RNA polymerase II regulatory region sequence-specific DNA binding |
Interacting selectively and non-covalently with a specific sequence of DNA that is part of a regulatory region that controls the transcription of a gene or cistron by RNA polymerase II. |
IDA |
MF |
GO:0001046 |
core promoter sequence-specific DNA binding |
Interacting selectively and non-covalently with a sequence of DNA that is part of a core promoter region composed of the transcription start site and binding sites for the basal transcription machinery. The transcribed region might be described as a gene, cistron, or operon. |
IDA |
MF |
GO:0001222 |
transcription corepressor binding |
Interacting selectively and non-covalently with a transcription corepressor, any protein involved in negative regulation of transcription via protein-protein interactions with transcription factors and other proteins that negatively regulate transcription. Transcription corepressors do not bind DNA directly, but rather mediate protein-protein interactions between repressing transcription factors and the basal transcription machinery. |
IPI |
MF |
GO:0001223 |
transcription coactivator binding |
Interacting selectively and non-covalently with a transcription coactivator, any protein involved in positive regulation of transcription via protein-protein interactions with transcription factors and other proteins that positively regulate transcription. Transcription coactivators do not bind DNA directly, but rather mediate protein-protein interactions between activating transcription factors and the basal transcription machinery. |
IPI |
MF |
GO:0003677 |
DNA binding |
Any molecular function by which a gene product interacts selectively and non-covalently with DNA (deoxyribonucleic acid). |
IDA |
MF |
GO:0003700 |
transcription factor activity, sequence-specific DNA binding |
Interacting selectively and non-covalently with a specific DNA sequence in order to modulate transcription. The transcription factor may or may not also interact selectively with a protein or macromolecular complex. |
IDA |
MF |
GO:0003707 |
steroid hormone receptor activity |
Combining with a steroid hormone and transmitting the signal within the cell to initiate a change in cell activity or function. |
IEA |
MF |
GO:0004879 |
RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding |
Combining with a signal and transmitting the signal to the transcriptional machinery by interacting selectively and non-covalently with a specific DNA sequence in order to modulate transcription by RNA polymerase II. |
IEA |
MF |
GO:0005515 |
protein binding |
Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules). |
IPI |
MF |
GO:0008013 |
beta-catenin binding |
Interacting selectively and non-covalently with the beta subunit of the catenin complex. |
IEA |
MF |
GO:0008134 |
transcription factor binding |
Interacting selectively and non-covalently with a transcription factor, any protein required to initiate or regulate transcription. |
IPI |
MF |
GO:0008142 |
oxysterol binding |
Interacting selectively and non-covalently with oxysterol, an oxidized form of cholesterol. |
IDA |
MF |
GO:0008270 |
zinc ion binding |
Interacting selectively and non-covalently with zinc (Zn) ions. |
IEA |
MF |
GO:0043565 |
sequence-specific DNA binding |
Interacting selectively and non-covalently with DNA of a specific nucleotide composition, e.g. GC-rich DNA binding, or with a specific sequence motif or type of DNA e.g. promotor binding or rDNA binding. |
IDA |
MF |
GO:0098531 |
transcription factor activity, direct ligand regulated sequence-specific DNA binding |
A DNA binding transcription factor activity that is directly regulated by binding of a ligand to the protein with this activity. Examples include the lac and trp repressors in E.coli and many steroid hormone receptors. |
IDA |
Domain ID | Description |
---|---|
IPR000536 |
Nuclear hormone receptor, ligand-binding domain |
IPR001628 |
Zinc finger, nuclear hormone receptor-type |
IPR001723 |
Nuclear hormone receptor |
IPR003079 |
Nuclear receptor ROR |
IPR013088 |
Zinc finger, NHR/GATA-type |
Pathway ID | Pathway Term | Pathway Source |
---|---|---|
hsa04659 |
Th17 cell differentiation |
KEGG |
hsa04710 |
Circadian rhythm |
KEGG |
hsa05321 |
Inflammatory bowel disease (IBD) |
KEGG |
WP3893 |
Development and heterogeneity of the ILC family |
WikiPathways |
WP706 |
Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways |
WikiPathways |
WP236 |
Adipogenesis |
WikiPathways |
WP3946 |
White fat cell differentiation |
WikiPathways |
WP3594 |
Circadian rythm related genes |
WikiPathways |
WP170 |
Nuclear Receptors |
WikiPathways |
UMLS CUI | UMLS Term |
---|---|
C0004096 |
Asthma |
C0004352 |
Autistic Disorder |
C0011570 |
Mental Depression |
C0031117 |
Peripheral Neuropathy |
C0038356 |
Stomach Neoplasms |
Tissue | Cell Type |
---|---|
appendix |
glandular cells |
bone marrow |
hematopoietic cells |
breast |
adipocytes |
bronchus |
respiratory epithelial cells |
caudate |
glial cells |
cerebellum |
cells in molecular layer |
cerebral cortex |
glial cells |
cervix, uterine |
glandular cells |
cervix, uterine |
squamous epithelial cells |
colon |
endothelial cells |
colon |
glandular cells |
duodenum |
glandular cells |
epididymis |
glandular cells |
esophagus |
squamous epithelial cells |
fallopian tube |
glandular cells |
gallbladder |
glandular cells |
heart muscle |
myocytes |
hippocampus |
glial cells |
liver |
hepatocytes |
lung |
macrophages |
lung |
pneumocytes |
nasopharynx |
respiratory epithelial cells |
oral mucosa |
squamous epithelial cells |
pancreas |
exocrine glandular cells |
placenta |
trophoblastic cells |
rectum |
glandular cells |
salivary gland |
glandular cells |
seminal vesicle |
glandular cells |
skin |
fibroblasts |
skin |
keratinocytes |
skin |
epidermal cells |
small intestine |
glandular cells |
soft tissue |
adipocytes |
soft tissue |
fibroblasts |
soft tissue |
peripheral nerve |
stomach |
glandular cells |
testis |
cells in seminiferous ducts |
testis |
Leydig cells |
tonsil |
germinal center cells |
tonsil |
non-germinal center cells |
tonsil |
squamous epithelial cells |
urinary bladder |
urothelial cells |
vagina |
squamous epithelial cells |
Pubmed ID | Author | Year | Title |
---|---|---|---|
22617121 |
Ouandaogo et al. |
2012 |
Differences in transcriptomic profiles of human cumulus cells isolated from oocytes at GV, MI and MII stages after in vivo andin vitro oocyte maturation |
22951915 |
Haozi et al. |
2012 |
Altered gene expression profile in cumulus cells of mature MII oocytes from patients with polycystic ovary syndrome |
Gene Symbol | Entrez ID | Uniprot ID | Score |
---|---|---|---|
CEBPB |
1051 |
P17676 |
0.63 |
EZH2 |
2146 |
Q15910 |
0.63 |
FLNB |
2317 |
O75369 |
0.63 |
PROX1 |
5629 |
Q92786 |
0.63 |
PTBP1 |
5725 |
P26599 |
0.63 |
RORA |
6095 |
P35398 |
0.63 |
VPRBP |
9730 |
Q9Y4B6 |
0.63 |
PNRC1 |
10957 |
Q12796 |
0.63 |
COPS5 |
10987 |
Q92905 |
0.63 |
PNRC2 |
55629 |
Q9NPJ4 |
0.63 |
LMO3 |
55885 |
Q8TAP4 |
0.63 |
DDB1 |
100290337 |
Q16531 |
0.63 |
RUVBL1 |
8607 |
Q9Y265 |
0.72 |
PSMC5 |
5705 |
P62195 |
0.74 |
NCOA1 |
8648 |
Q15788 |
0.74 |
NME2 |
4831 |
P22392 |
0.75 |
MYOD1 |
4654 |
P15172 |
0.85 |
NME1 |
4830 |
P15531 |
0.88 |
LRIF1 |
55791 |
Q5T3J3 |
0.56 |
SMARCD3 |
6604 |
Q6STE5 |
0.59 |
CSNK1E |
1454 |
P49674 |
0.63 |
GFAP |
2670 |
P14136 |
0.63 |
EIF3I |
8668 |
Q13347 |
0.63 |
NSD1 |
64324 |
Q96L73 |
0.63 |
ZXDC |
79364 |
Q2QGD7 |
0.63 |
BHLHE41 |
79365 |
Q9C0J9 |
0.63 |
FOXP3 |
50943 |
Q9BZS1 |
0.72 |
NR0B1 |
190 |
P51843 |
0.75 |
NCOA2 |
10499 |
Q15596 |
0.75 |
MED1 |
5469 |
Q15648 |
0.77 |
EP300 |
2033 |
Q09472 |
0.88 |